OTC: COGZF - Cogstate Limited

Yield per half year: -25.93%
Sector: Healthcare

Share chart Cogstate Limited

Extended chart Simple chart
Financial Markets by TradingView

About

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments.

More details
The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Цена ао 0.83
Выручка 0.0311
EBITDA -0.0047
Число акций ао 0.17319 млрд
P/E 37.25
P/S 0.5359
P/BV 1.16
Сайт https://www.cogstate.com
Валюта usd
Sector Health Care
Industry Health Care Technology
Валюта отчета usd
Change price per day: +0.8065% (0.5952)
Change price per week: +1.69% (0.59)
Change price per month: -6.25% (0.64)
Change price per 3 month: -20% (0.75)
Change price per half year: -25.93% (0.81)
Change price per year: -28.57% (0.84)
Change price per 3 year: -63.86% (1.66)
Change price per 5 year: -34.07% (0.91)
Change price per year to date: -37.5% (0.96)
All parameters

Underestimation

Title Value Grade
P/S 2.87 6
P/BV 3.05 5
P/E 22.88 6
EV/EBITDA 0 0
Total: 6.13

Efficiency

Title Value Grade
ROA, % 9.42 3
ROE, % 13.32 4
Total: 2.83

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 25.88 4
Yield Ebitda, % -221.06 0
Yield EPS, % -382.41 0
Total: 0.8
More

Institutions Volume Share, %
Bard Financial Services, INC. 12500 0.01



Head Job title Payment Year of birth
Prof. Paul Maruff BBSc (Hons), Ph.D. Founder & Chief Innovation Officer N/A
Mr. Darren Watson Chief Financial Officer 356.18k
Mr. Kenneth Billard Chief Commercial Officer 417.18k
Ms. Rachel Colite Executive VP of Clinical Trials 290.87k
Ms. Kristi Geddes General Counsel, Joint Company Secretary & Director N/A
Mr. David James Franks BEc, C.A., F Fin, J.P. Joint Company Secretary N/A 1970 (54 years)
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Executive Director

Address: Australia, Melbourne. VIC, 367 Collins Street - open in Google maps, open in Yandex maps
Website: https://www.cogstate.com